Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR Data: All Age Groups
Percentage of Specimens Positive
August 2023:
- Rhino/Enterovirus: 34.2%
- Rhinovirus: 29.3%
- SARS-CoV-2: 9.47%
- RSV: 3.1%
- Parainfluenza 1-4: 8.3%
- Human metapneumovirus: 9.2%
- Coronavirus (non-SARS-CoV-2): 1.7%
- Influenza A: 7.2%
- Influenza B: 1.7%
- Adenovirus: 8.8%
- Bordetella pertussis: 0.9%
- Bordetella parapertussis: 0.5%
September 2023:
- Rhino/Enterovirus: 29.3%
- Rhinovirus: 24.8%
- SARS-CoV-2: 13.0%
- RSV: 2.6%
- Parainfluenza 1-4: 12.4%
- Human metapneumovirus: 2.2%
- Coronavirus (non-SARS-CoV-2): 3.2%
- Influenza A: 7.7%
- Influenza B: 4.3%
- Adenovirus: 5.7%
- Bordetella pertussis: 0.9%
- Bordetella parapertussis: 2.2%
Epidemiological Weeks 1 - 39:
- SARS-CoV-2: Positivity rate increased from 10.1% (week 35) to 13.8% (week 39).
- RSV A&B: Positivity remained low, at 2.4% (week 39).
- Influenza A: Low positivity rate of 1% in week 39.
- Influenza B: Positivity increased from 1.4% (week 35) to 2.4% (week 39).
Atypical Bacterial Pathogens (Weeks 1 - 39):
Bordetella pertussis:
- Total cases: 497
- Most affected groups:
- 0 - 6 months: 25%
- 6 - 12 years: 22%
- 1 - 5 years: 19% 18 years: 23%
Weekly Cases (Weeks 1 - 39):
8, 7, 5, 16, 13, 4, 6, 8, 9, 9, 7, 11, 16, 10, 15, 19, 13, 13, 17, 9, 13, 23, 21, 11, 16, 13, 17, 9, 21, 27, 15, 11, 9, 18, 10, 16, 11, 8, 13
Bordetella parapertussis (Weeks 1 - 39):
- Very low case numbers recorded.
Mycoplasma pneumoniae:
- Total cases: 1383 (peaked at week 25 with 72 cases)
- Most affected groups:
- 1 - 5 years: 39%
- 6 - 12 years: 28%
Weekly Cases (Weeks 1 - 39):
4, 6, 10, 7, 5, 11, 12, 17, 12, 18, 25, 30, 23, 34, 37, 36, 34, 42, 42, 52, 46, 63, 62, 57, 72, 48, 57, 53, 45, 46, 48, 41, 40, 49, 41, 36, 41, 48, 33
Paediatric Respiratory Viral Multiplex PCR Data (0 – 12 years):
<1 year Age Group - Specimen Positivity:
August 2023:
- Rhino/Enterovirus: 43.3%
- Rhinovirus: 39.1%
- Parainfluenza 1-4: 12.9%
- Adenovirus: 13.3%
- RSV: 8.6%
- Influenza A: 9.8%
- Influenza B: 1.7%
- SARS-CoV-2: 13.1%
September 2023:
- Rhino/Enterovirus: 39.0%
- Rhinovirus: 30.2%
- Parainfluenza 1-4: 19.1%
- Adenovirus: 13.1%
- RSV: 6.2%
- Influenza A: 4.4%
- Influenza B: 6.2%
- SARS-CoV-2: 4.8%
1 - 5 year Age Group - Specimen Positivity:
August 2023:
- Rhino/Enterovirus: 49.0%
- Rhinovirus: 40.0%
- Parainfluenza 1-4: 14.2%
- Adenovirus: 13.2%
- RSV: 4.3%
- Influenza A: 16.0%
- Influenza B: 4.1%
- SARS-CoV-2: 17.1%
September 2023:
- Rhino/Enterovirus: 46.3%
- Rhinovirus: 38.6%
- Parainfluenza 1-4: 18.3%
- Adenovirus: 17.1%
- RSV: 3.5%
- Influenza A: 6.4%
- Influenza B: 6.3%
- SARS-CoV-2: 14.0%
6 - 12 year Age Group - Specimen Positivity:
August 2023:
- Rhino/Enterovirus: 44.2%
- Rhinovirus: 36.1%
- Parainfluenza 1-4: 4.6%
- Adenovirus: 8.4%
- RSV: 1.9%
- Influenza A: 5.1%
- Influenza B: 0.0%
- SARS-CoV-2: 5.4%
September 2023:
- Rhino/Enterovirus: 29.4%
- Rhinovirus: 33.5%
- Parainfluenza 1-4: 9.6%
- Adenovirus: 6.2%
- RSV: 1.4%
- Influenza A: 1.3%
- Influenza B: 6.2%
- SARS-CoV-2: 4.5%
Additional Comments:
- Most frequently detected viruses in September 2023:
- <1 year: Rhino/Enterovirus, Rhinovirus, Parainfluenza 1-4, Adenovirus.
- 1 - 5 years: Rhino/Enterovirus, Rhinovirus, Parainfluenza 1-4, Adenovirus.
- 6 - 12 years: Rhinovirus, Rhino/Enterovirus, Parainfluenza 1-4.
- Significant increase in Influenza B positivity in the 6–12-year age group (from 0.9% in August to 6.2% in September).
Continue Reading